Company
ChinaSinopharm Weiqida Pharmaceutical Co. Ltd., Datong, China – FDA Inspections
Inspection records and compliance data for Sinopharm Weiqida Pharmaceutical Co. Ltd. in Datong. 3 FDA inspections on record, 1 Form 483, last inspected May 25, 2023.
Company Profile
This profile covers Sinopharm Weiqida Pharmaceutical Co. Ltd. based in Datong, China.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected May 1, 2015. Last inspected May 25, 2023.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 25, 2023 | VAI | Human Drugs · Drug Quality Assurance | 1209420 |
| July 21, 2017 | NAI | Human Drugs · Drug Quality Assurance | 1028876 |
| May 1, 2015 | NAI | Human Drugs · Drug Quality Assurance | 932412 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Zhejiang Starry Pharmaceutical Co. Ltd.
Hubei Enoray Biopharmaceutical Co., Ltd.
Zhejiang Chiral Medicine Chemicals Co., Ltd.
Sinobest Cosmeceutical Co., Ltd.
Shandong Keyuan Pharmaceutical Co., Ltd.
Shanghai Soho-Yiming Pharmaceuticals Co., Ltd.
Chongqing Carelife Pharmaceutical Co., Ltd.
Tianjin Weijie Pharmaceutical Co., Ltd.
Jiangsu Jiafu Pharmaceutical Co., Ltd.
Shandong Apeloa Tospo Pharmaceutical Co., Ltd.
Company Information
Name
Sinopharm Weiqida Pharmaceutical Co. Ltd.
FEI Number
3010166430
Address
Pharmaceutical Industrial Park, Economic & Technological Development Zone, Datong, China
Country
China
ID: 84a9a7f6-77bd-4e05-b016-5ccda3f0ea97